Tech Company Financing Transactions
Synthego Funding Round
On 3/1/2022, Synthego raised $200 million in Series E financing from Perceptive Advisors, Chimera Partners and Declaration Partners.
Transaction Overview
Company Name
Announced On
3/1/2022
Transaction Type
Venture Equity
Amount
$200,000,000
Round
Series E
Investors
Perceptive Advisors (Lead Investor) (Mike Altman)
RA Capital (Nathaniel Horwitz)
Proceeds Purpose
Synthego will use the proceeds from the Series E financing to accelerate the creation of a cell and gene therapy discovery and development ecosystem to help researchers scale and simplify the translation of new discoveries into novel therapeutics for serious diseases.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3696 Haven Ave.
Redwood City, CA 94063
USA
Redwood City, CA 94063
USA
Phone
Website
Email Address
Overview
Synthego is a genome engineering company that enables the acceleration of life science research and development in the pursuit of improved human health.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Dabrowski
Browse more venture capital transactions:
Prev: 3/1/2022: Mizar venture capital transaction
Next: 3/1/2022: Thetanuts Finance venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records reported here come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs